Exploring bacterial extracellular vesicles: Focus on WHO critical priority pathogens

Area of Science:

• Microbiology
• Immunology
• Biotechnology

Background:

• Bacterial extracellular vesicles (EVs) are nanoparticles involved in intercellular communication and pathogenesis.
• EVs contain diverse biomolecules, including proteins, lipids, DNA, and RNA.
• They hold significant potential for biomedical applications like drug delivery, vaccines, and diagnostics.

Purpose of the Study:

• To review the clinical relevance of bacterial EVs.
• To focus on outer membrane vesicles (OMVs) from Acinetobacter baumannii and Klebsiella pneumoniae.
• To explore OMV-based vaccine strategies against these pathogens.

Main Methods:

• Literature review focusing on bacterial EVs, specifically OMVs.
• Analysis of the role of OMVs in antimicrobial resistance and pathogenicity.
• Evaluation of OMV-based vaccine development.

Main Results:

• Bacterial EVs are crucial mediators of bacterial and host functions.
• OMVs from A. baumannii and K. pneumoniae are implicated in antimicrobial resistance and pathogenicity.
• OMV-derived vaccines show promise for mitigating infections caused by these critical pathogens.

Conclusions:

• Bacterial EVs, particularly OMVs, are significant in clinical contexts.
• Targeting OMVs offers a potential strategy for combating challenging bacterial pathogens.
• Further research into OMV-based vaccines is warranted for therapeutic development.